Literature DB >> 17658460

Matrin 3 is a Ca2+/calmodulin-binding protein cleaved by caspases.

C Alexander Valencia1, Wujian Ju, Rihe Liu.   

Abstract

Matrin 3 is a nuclear matrix protein that has been implicated in interacting with other nuclear proteins to anchor hyperedited RNAs to the nuclear matrix, in modulating the activity of proximal promoters, and as the main PKA substrate following NMDA receptor activation. In our proteome-wide selections for calmodulin (CaM) binding proteins and for caspase substrates using mRNA-displayed human proteome libraries, matrin 3 was identified as both a Ca(2+)-dependent CaM-binding protein and a downstream substrate of caspases. We report here, the in vitro characterization of the CaM-binding motif and the caspase cleavage site on matrin 3. Significantly, the Ca(2+)/CaM-binding motif is partially overlapped by the RRM of matrin 3 and is also very close to the bipartite NLS that is essential for its nuclear localization. The caspase cleavage site is downstream of the NLS but upstream of the second U1-like zinc finger. Our results suggest that the functions of matrin 3 could be regulated by both Ca(2+)-dependent interaction with CaM and caspase-mediated cleavage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17658460     DOI: 10.1016/j.bbrc.2007.06.156

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

Authors:  D Allan Butterfield; Marzia Perluigi; Tanea Reed; Tasneem Muharib; Christopher P Hughes; Renã A S Robinson; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

2.  A study of FHL1, BAG3, MATR3, PTRF and TCAP in Australian muscular dystrophy patients.

Authors:  Leigh B Waddell; Jenny Tran; Xi F Zheng; Carsten G Bönnemann; Ying Hu; Frances J Evesson; Monkol Lek; Susan Arbuckle; Min-Xia Wang; Robert L Smith; Kathryn N North; Nigel F Clarke
Journal:  Neuromuscul Disord       Date:  2011-06-17       Impact factor: 4.296

3.  Herpes simplex virus 1 ICP4 forms complexes with TFIID and mediator in virus-infected cells.

Authors:  Jonathan T Lester; Neal A DeLuca
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

4.  Changes in leukocyte gene expression profiles induced by antineoplastic chemotherapy.

Authors:  Rebeca González-Fernández; Manuel Morales; Julio Avila; Pablo Martín-Vasallo
Journal:  Oncol Lett       Date:  2012-04-03       Impact factor: 2.967

5.  Proteomic analysis of nuclei isolated from cancer cell lines treated with indenoisoquinoline NSC 724998, a novel topoisomerase I inhibitor.

Authors:  Bingnan Han; Luke H Stockwin; Chad Hancock; Sherry X Yu; Melinda G Hollingshead; Dianne L Newton
Journal:  J Proteome Res       Date:  2010-08-06       Impact factor: 4.466

6.  In vitro selection of proteins with desired characteristics using mRNA-display.

Authors:  C Alexander Valencia; Jianwei Zou; Rihe Liu
Journal:  Methods       Date:  2012-11-28       Impact factor: 3.608

7.  Matrin 3 binds and stabilizes mRNA.

Authors:  Maayan Salton; Ran Elkon; Tatiana Borodina; Aleksey Davydov; Marie-Laure Yaspo; Eran Halperin; Yosef Shiloh
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

Review 8.  Calcium dysregulation links ALS defective proteins and motor neuron selective vulnerability.

Authors:  Sónia S Leal; Cláudio M Gomes
Journal:  Front Cell Neurosci       Date:  2015-06-16       Impact factor: 5.505

9.  Differences of immune disorders between Alzheimer's disease and breast cancer based on transcriptional regulation.

Authors:  Wei Kong; Xiaoyang Mou; Jin Deng; Benteng Di; Ruxing Zhong; Shuaiqun Wang; Yang Yang; Weiming Zeng
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

10.  Phosphoproteome Profiling of SH-SY5y Neuroblastoma Cells Treated with Anesthetics: Sevoflurane and Isoflurane Affect the Phosphorylation of Proteins Involved in Cytoskeletal Regulation.

Authors:  Joomin Lee; Eunsook Ahn; Wyun Kon Park; Seyeon Park
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.